rolipram has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Y | 1 |
| Zhu, Y | 1 |
| He, T | 1 |
| Li, W | 1 |
| Yan, H | 1 |
| Miao, Y | 1 |
1 other study available for rolipram and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels.
Topics: Animals; Apoptosis Regulatory Proteins; Brain-Derived Neurotrophic Factor; Cognition; Cognition Diso | 2016 |